Huperzine for Cognitive and Functional Impairment in Schizophrenia

This study has been completed.
Sponsor:
Collaborator:
Yale University
Information provided by (Responsible Party):
Scott Woods, MD, Biomedisyn Corporation
ClinicalTrials.gov Identifier:
NCT00963846
First received: August 10, 2009
Last updated: February 28, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)